| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF355P SOX9 SOX10 ZNF268 ZNF875 ZNF549 ZFP30 ESR2 TBX21 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 TFE3 ZNF404 ZNF461 EOMES ZNF594 ZNF836 TFCP2L1 ZNF33B ZNF35 ZNF341 ZNF540 ZBTB21 ZNF727 ZNF420 TBR1 ZNF471 ZNF454 ZNF292 VDR ZNF646 | 4.06e-07 | 1412 | 189 | 34 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF355P SOX9 SOX10 ZNF268 ZNF875 ZNF549 ZFP30 ESR2 TBX21 ZNF521 ZFP28 ZNF621 BCOR ZNF354B ZFP37 TFE3 ZNF404 ZNF461 EOMES ZNF594 ZNF836 TFCP2L1 ZNF33B ZNF35 ZNF341 ZNF540 ZNF727 ZNF420 TBR1 ZNF471 ZNF454 VDR ZNF646 | 2.45e-06 | 1459 | 189 | 33 | GO:0000977 |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK8 SMG1 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 MAP3K5 PRKAA1 EIF2AK4 MAPK3 DCLK1 DYRK3 | 9.88e-06 | 363 | 189 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF355P SOX9 SOX10 ZNF268 ZNF549 ZFP30 ESR2 TBX21 ZNF521 ZFP28 ZNF621 ZNF354B TFE3 ZNF461 EOMES ZNF594 ZNF836 TFCP2L1 ZNF33B ZNF341 ZNF540 ZNF727 ZNF420 TBR1 ZNF471 ZNF454 VDR ZNF646 | 1.73e-05 | 1244 | 189 | 28 | GO:0000978 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK8 SMG1 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 2.38e-05 | 446 | 189 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF355P SOX9 SOX10 ZNF268 ZNF549 ZFP30 ESR2 TBX21 ZNF521 ZFP28 ZNF621 ZNF354B TFE3 ZNF461 EOMES ZNF594 ZNF836 TFCP2L1 ZNF33B ZNF341 ZNF540 ZNF727 ZNF420 TBR1 ZNF471 ZNF454 VDR ZNF646 | 2.54e-05 | 1271 | 189 | 28 | GO:0000987 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK8 GPHN SMG1 KALRN NEK10 MAPKAPK2 RPS6KA1 GNPTAB PIK3R3 NME2P1 DAPK1 RIPK4 TEX14 TRRAP MAP3K5 PRKAA1 UBA6 IRAK3 EIF2AK4 MAPK3 POLQ DCLK1 DYRK3 | 2.84e-05 | 938 | 189 | 23 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 9.54e-05 | 10 | 189 | 3 | GO:0140031 | |
| GeneOntologyMolecularFunction | kinase activity | CDK8 SMG1 KALRN NEK10 MAPKAPK2 RPS6KA1 PIK3R3 NME2P1 DAPK1 RIPK4 TEX14 TRRAP MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 1.22e-04 | 764 | 189 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK8 SMG1 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 TEX14 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 1.97e-04 | 600 | 189 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK8 SMG1 KALRN NEK10 MAPKAPK2 RPS6KA1 PIK3R3 DAPK1 RIPK4 TEX14 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 4.27e-04 | 709 | 189 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SOX9 SOX10 ZNF268 ESR2 TBX21 ZNF521 TFE3 ZNF594 ZNF836 TFCP2L1 ZNF33B ZNF341 ZNF727 ZNF292 | 1.03e-03 | 566 | 189 | 14 | GO:0001216 |
| Domain | - | ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF654 ZNF292 ZNF646 | 2.18e-08 | 679 | 188 | 25 | 3.30.160.60 |
| Domain | Znf_C2H2-like | BNC2 ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 TAX1BP1 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF654 ZNF292 ZNF646 | 3.11e-08 | 796 | 188 | 27 | IPR015880 |
| Domain | zf-C2H2 | BNC2 ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF292 ZNF646 | 3.25e-08 | 693 | 188 | 25 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF654 ZNF292 ZNF646 | 3.34e-08 | 694 | 188 | 25 | IPR013087 |
| Domain | Znf_C2H2 | BNC2 ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 TAX1BP1 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF654 ZNF292 ZNF646 | 3.92e-08 | 805 | 188 | 27 | IPR007087 |
| Domain | ZnF_C2H2 | BNC2 ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 TAX1BP1 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF654 ZNF292 ZNF646 | 4.23e-08 | 808 | 188 | 27 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | BNC2 ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF654 ZNF292 ZNF646 | 7.16e-08 | 775 | 188 | 26 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | BNC2 ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF654 ZNF292 ZNF646 | 7.53e-08 | 777 | 188 | 26 | PS00028 |
| Domain | KRAB | ZNF268 ZNF875 ZNF549 ZFP30 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF836 ZNF33B ZNF540 ZNF727 ZNF420 ZNF471 ZNF454 | 1.36e-07 | 358 | 188 | 17 | PS50805 |
| Domain | KRAB | ZNF268 ZNF875 ZNF549 ZFP30 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF836 ZNF33B ZNF540 ZNF727 ZNF420 ZNF471 ZNF454 | 1.36e-07 | 358 | 188 | 17 | PF01352 |
| Domain | KRAB | ZNF268 ZNF875 ZNF549 ZFP30 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF836 ZNF33B ZNF540 ZNF727 ZNF420 ZNF471 ZNF454 | 2.09e-07 | 369 | 188 | 17 | SM00349 |
| Domain | KRAB | ZNF268 ZNF875 ZNF549 ZFP30 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF836 ZNF33B ZNF540 ZNF727 ZNF420 ZNF471 ZNF454 | 2.17e-07 | 370 | 188 | 17 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF836 ZNF540 ZNF727 ZNF420 ZNF646 | 3.76e-06 | 314 | 188 | 14 | PF13912 |
| Domain | DEATH | 6.61e-06 | 27 | 188 | 5 | SM00005 | |
| Domain | Kinase-like_dom | CDK8 SMG1 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 TEX14 TRRAP MAP3K5 PTPN13 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 9.71e-06 | 542 | 188 | 18 | IPR011009 |
| Domain | Death | 1.85e-05 | 33 | 188 | 5 | PF00531 | |
| Domain | Pkinase | CDK8 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 3.31e-05 | 381 | 188 | 14 | PF00069 |
| Domain | Death_domain | 3.76e-05 | 38 | 188 | 5 | IPR000488 | |
| Domain | DEATH_DOMAIN | 3.76e-05 | 38 | 188 | 5 | PS50017 | |
| Domain | MHC_II_b_N | 5.42e-05 | 8 | 188 | 3 | PD000328 | |
| Domain | Ser/Thr_kinase_AS | CDK8 KALRN MAPKAPK2 RPS6KA1 DAPK1 RIPK4 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 6.97e-05 | 357 | 188 | 13 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | CDK8 KALRN MAPKAPK2 RPS6KA1 DAPK1 RIPK4 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 8.01e-05 | 362 | 188 | 13 | PS00108 |
| Domain | MHC_II_b_N | 8.06e-05 | 9 | 188 | 3 | IPR000353 | |
| Domain | MHC_II_beta | 8.06e-05 | 9 | 188 | 3 | SM00921 | |
| Domain | MHC_II_beta | 8.06e-05 | 9 | 188 | 3 | PF00969 | |
| Domain | ZU5 | 8.06e-05 | 9 | 188 | 3 | SM00218 | |
| Domain | T-box_assoc | 1.01e-04 | 2 | 188 | 2 | PF16176 | |
| Domain | T-box_assoc | 1.01e-04 | 2 | 188 | 2 | IPR032385 | |
| Domain | ZU5 | 1.14e-04 | 10 | 188 | 3 | PS51145 | |
| Domain | Prot_kinase_dom | CDK8 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 TEX14 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 1.33e-04 | 489 | 188 | 15 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK8 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 TEX14 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 1.46e-04 | 493 | 188 | 15 | PS50011 |
| Domain | ZU5 | 2.07e-04 | 12 | 188 | 3 | PF00791 | |
| Domain | ZU5_dom | 2.07e-04 | 12 | 188 | 3 | IPR000906 | |
| Domain | ANK | ANKRD31 ASZ1 ANK2 ANK3 ANKRD30B DAPK1 RIPK4 TEX14 BCOR TRANK1 | 2.37e-04 | 251 | 188 | 10 | SM00248 |
| Domain | PROTEIN_KINASE_ATP | CDK8 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 RIPK4 MAP3K5 PRKAA1 IRAK3 EIF2AK4 MAPK3 DCLK1 DYRK3 | 2.37e-04 | 459 | 188 | 14 | PS00107 |
| Domain | ANK_REPEAT | ANKRD31 ASZ1 ANK2 ANK3 ANKRD30B DAPK1 RIPK4 TEX14 BCOR TRANK1 | 2.52e-04 | 253 | 188 | 10 | PS50088 |
| Domain | ANK_REP_REGION | ANKRD31 ASZ1 ANK2 ANK3 ANKRD30B DAPK1 RIPK4 TEX14 BCOR TRANK1 | 2.60e-04 | 254 | 188 | 10 | PS50297 |
| Domain | S_TKc | CDK8 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 MAP3K5 PRKAA1 EIF2AK4 MAPK3 DCLK1 DYRK3 | 2.92e-04 | 359 | 188 | 12 | SM00220 |
| Domain | Sox_N | 3.00e-04 | 3 | 188 | 2 | IPR022151 | |
| Domain | Sox_N | 3.00e-04 | 3 | 188 | 2 | PF12444 | |
| Domain | Torsin_1/2 | 3.00e-04 | 3 | 188 | 2 | IPR017378 | |
| Domain | Ankyrin_rpt | ANKRD31 ASZ1 ANK2 ANK3 ANKRD30B DAPK1 RIPK4 TEX14 BCOR TRANK1 | 3.33e-04 | 262 | 188 | 10 | IPR002110 |
| Domain | MHC_II_a/b_N | 3.37e-04 | 14 | 188 | 3 | IPR014745 | |
| Domain | - | 3.37e-04 | 14 | 188 | 3 | 3.10.320.10 | |
| Domain | Protein_kinase_ATP_BS | CDK8 KALRN NEK10 MAPKAPK2 RPS6KA1 DAPK1 MAP3K5 PRKAA1 EIF2AK4 MAPK3 DCLK1 DYRK3 | 4.75e-04 | 379 | 188 | 12 | IPR017441 |
| Domain | Ank | 5.18e-04 | 228 | 188 | 9 | PF00023 | |
| Domain | Tox-GHH_dom | 5.97e-04 | 4 | 188 | 2 | IPR028916 | |
| Domain | RetinoicA-induced_16-like | 5.97e-04 | 4 | 188 | 2 | IPR019384 | |
| Domain | RAI16-like | 5.97e-04 | 4 | 188 | 2 | PF10257 | |
| Domain | Tox-GHH | 5.97e-04 | 4 | 188 | 2 | PF15636 | |
| Domain | Ten_N | 5.97e-04 | 4 | 188 | 2 | IPR009471 | |
| Domain | Ten_N | 5.97e-04 | 4 | 188 | 2 | PF06484 | |
| Domain | TENEURIN_N | 5.97e-04 | 4 | 188 | 2 | PS51361 | |
| Domain | TF_T-box | 6.15e-04 | 17 | 188 | 3 | IPR001699 | |
| Domain | TBOX | 6.15e-04 | 17 | 188 | 3 | SM00425 | |
| Domain | TF_T-box_CS | 6.15e-04 | 17 | 188 | 3 | IPR018186 | |
| Domain | - | 6.15e-04 | 17 | 188 | 3 | 2.60.40.820 | |
| Domain | TBOX_3 | 6.15e-04 | 17 | 188 | 3 | PS50252 | |
| Domain | T-box | 6.15e-04 | 17 | 188 | 3 | PF00907 | |
| Domain | TBOX_1 | 6.15e-04 | 17 | 188 | 3 | PS01283 | |
| Domain | TBOX_2 | 6.15e-04 | 17 | 188 | 3 | PS01264 | |
| Domain | ARM-type_fold | 6.67e-04 | 339 | 188 | 11 | IPR016024 | |
| Domain | HEAT_REPEAT | 6.98e-04 | 70 | 188 | 5 | PS50077 | |
| Domain | - | 9.43e-04 | 248 | 188 | 9 | 1.25.40.20 | |
| Domain | YD | 9.88e-04 | 5 | 188 | 2 | IPR006530 | |
| Domain | Torsin | 9.88e-04 | 5 | 188 | 2 | PF06309 | |
| Domain | Torsin | 9.88e-04 | 5 | 188 | 2 | IPR010448 | |
| Domain | Ankyrin_rpt-contain_dom | 1.11e-03 | 254 | 188 | 9 | IPR020683 | |
| Domain | FAT | 1.47e-03 | 6 | 188 | 2 | PS51189 | |
| Domain | FATC | 1.47e-03 | 6 | 188 | 2 | PS51190 | |
| Domain | FATC_dom | 1.47e-03 | 6 | 188 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.47e-03 | 6 | 188 | 2 | IPR014009 | |
| Domain | FATC | 1.47e-03 | 6 | 188 | 2 | SM01343 | |
| Domain | Ank_2 | 1.54e-03 | 215 | 188 | 8 | PF12796 | |
| Domain | ClpA/B | 2.05e-03 | 7 | 188 | 2 | IPR001270 | |
| Domain | - | 2.49e-03 | 93 | 188 | 5 | 1.10.533.10 | |
| Domain | HEAT | 2.76e-03 | 58 | 188 | 4 | IPR000357 | |
| Domain | DEATH-like_dom | 3.27e-03 | 99 | 188 | 5 | IPR011029 | |
| Domain | - | 5.06e-03 | 207 | 188 | 7 | 1.25.40.10 | |
| Domain | aa-tRNA-synt_IIb | 5.22e-03 | 11 | 188 | 2 | IPR002314 | |
| Domain | - | 5.22e-03 | 11 | 188 | 2 | 3.40.50.800 | |
| Domain | tRNA-synt_2b | 5.22e-03 | 11 | 188 | 2 | PF00587 | |
| Domain | ARM-like | 6.14e-03 | 270 | 188 | 8 | IPR011989 | |
| Domain | MHC_I/II-like_Ag-recog | 6.54e-03 | 38 | 188 | 3 | IPR011162 | |
| Domain | NHL | 7.31e-03 | 13 | 188 | 2 | PS51125 | |
| Domain | - | 7.34e-03 | 222 | 188 | 7 | 1.25.10.10 | |
| Domain | VitD_rcpt | 8.47e-03 | 14 | 188 | 2 | IPR000324 | |
| Domain | Anticodon-bd | 8.47e-03 | 14 | 188 | 2 | IPR004154 | |
| Domain | TPR-like_helical_dom | 9.44e-03 | 233 | 188 | 7 | IPR011990 | |
| Pubmed | ZNF355P SCRN3 AOC1 CAND2 ANK3 VPS39 RAPGEF5 AHCTF1 UNC13D CEP192 BCOR COPS2 ZFP37 LCLAT1 PTPN13 RESF1 ZNF341 ABCE1 DDHD1 PRKAA1 ARID5B EIF2AK4 DCLK1 FHIP2B | 7.73e-09 | 1084 | 191 | 24 | 11544199 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 20371654 | ||
| Pubmed | Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. | 1.63e-07 | 3 | 191 | 3 | 16815190 | |
| Pubmed | Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. | 1.63e-07 | 3 | 191 | 3 | 8775462 | |
| Pubmed | Developmental expression of the T-box transcription factor T-bet/Tbx21 during mouse embryogenesis. | 1.63e-07 | 3 | 191 | 3 | 12128215 | |
| Pubmed | A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. | 1.63e-07 | 3 | 191 | 3 | 12008082 | |
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 14677183 | ||
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 19922436 | ||
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 17002906 | ||
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 6.50e-07 | 4 | 191 | 3 | 12144077 | |
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 18520346 | ||
| Pubmed | HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis. | 6.50e-07 | 4 | 191 | 3 | 15795121 | |
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 6.50e-07 | 4 | 191 | 3 | 3476943 | |
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 26740600 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDK8 DYM DEPTOR ANK3 MAPKAPK2 ZNF875 PIK3R3 BTAF1 CEP192 CPT1A TRRAP ZNF461 PTPN13 ZNF33B CBFA2T2 HS2ST1 ARID5B UBA6 FNIP1 TTC17 EIF2AK4 UBE3C SPIDR HTT DOP1A | 7.21e-07 | 1489 | 191 | 25 | 28611215 |
| Pubmed | Heparan sulfotransferases Hs6st1 and Hs2st keep Erk in check for mouse corpus callosum development. | 8.45e-07 | 14 | 191 | 4 | 24501377 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MAN2A2 KALRN MYO9B VPS39 MAPKAPK2 BTAF1 CEP192 TRRAP BIRC6 LYST TFE3 MAP3K5 ITPR2 FOCAD ZCCHC14 FASN ZNF341 DEF6 UBE3C MED13 HTT | 8.67e-07 | 1105 | 191 | 21 | 35748872 |
| Pubmed | Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. | 1.52e-06 | 16 | 191 | 4 | 9223324 | |
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 17910142 | ||
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 16973583 | ||
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 12209103 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 1.62e-06 | 5 | 191 | 3 | 17182961 | |
| Pubmed | HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. | 1.62e-06 | 5 | 191 | 3 | 17763415 | |
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 11782380 | ||
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 23152536 | ||
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 17411376 | ||
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 16916662 | ||
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 1.62e-06 | 5 | 191 | 3 | 12144632 | |
| Pubmed | Tbt-1, a new T-box transcription factor induced in activated Th1 and CD8+ T cells. | 1.62e-06 | 5 | 191 | 3 | 10970091 | |
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 1.62e-06 | 5 | 191 | 3 | 1970352 | |
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 7645219 | ||
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 12392858 | ||
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 15908298 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 1.62e-06 | 5 | 191 | 3 | 17507489 | |
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 7734415 | ||
| Pubmed | Neurogenesis and neuronal migration in the forebrain of the TorsinA knockout mouse embryo. | 1.62e-06 | 5 | 191 | 3 | 23018676 | |
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 1.62e-06 | 5 | 191 | 3 | 20606439 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 1.62e-06 | 5 | 191 | 3 | 12202216 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GPHN CAND2 RPS6KA1 NUP88 CPT1A MRPS22 TYMS IGF2BP1 FASN ABCE1 AGL PRKAA1 TTC17 STIP1 CDC73 PLD2 UBE3C MAPK3 NUP160 | 2.04e-06 | 974 | 191 | 19 | 28675297 |
| Pubmed | HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. | 2.54e-06 | 18 | 191 | 4 | 19620308 | |
| Pubmed | 2.94e-06 | 272 | 191 | 10 | 31010829 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 17153701 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 18305173 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 15902698 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 11082517 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 11997714 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 18223493 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 19233472 | ||
| Pubmed | Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. | 3.22e-06 | 6 | 191 | 3 | 20696378 | |
| Pubmed | Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. | 3.22e-06 | 6 | 191 | 3 | 3372263 | |
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 3.22e-06 | 6 | 191 | 3 | 19235017 | |
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 15896200 | ||
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 3.22e-06 | 6 | 191 | 3 | 14508706 | |
| Pubmed | SMG1 MAN2A2 CAND2 NRAP ANK2 KALRN SRP72 BIRC6 MAP3K5 AGL TAX1BP1 STIP1 MED13 | 4.21e-06 | 497 | 191 | 13 | 23414517 | |
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 18569076 | ||
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 5.61e-06 | 7 | 191 | 3 | 12230470 | |
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 31676673 | ||
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 5.61e-06 | 7 | 191 | 3 | 18846964 | |
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 20307907 | ||
| Pubmed | 5.97e-06 | 22 | 191 | 4 | 35245678 | ||
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | SCRN3 OXER1 MOGAT1 TFCP2L1 SAG TENM3 BBS7 UCP1 UBA6 ABHD1 TBR1 HTT | 6.84e-06 | 442 | 191 | 12 | 15815621 |
| Pubmed | SMG1 CAND2 VPS39 BCOR TRANK1 WASHC5 DDHD1 HS2ST1 ZBTB21 EIF2AK4 NDRG4 MED13 ZNF646 | 8.21e-06 | 529 | 191 | 13 | 14621295 | |
| Pubmed | Regional differences in mitral cell development in mouse olfactory bulb. | 8.95e-06 | 8 | 191 | 3 | 30864157 | |
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 8.95e-06 | 8 | 191 | 3 | 16405603 | |
| Pubmed | 8.95e-06 | 8 | 191 | 3 | 23729440 | ||
| Pubmed | 8.95e-06 | 8 | 191 | 3 | 19223392 | ||
| Pubmed | 8.95e-06 | 8 | 191 | 3 | 12296785 | ||
| Pubmed | 8.95e-06 | 8 | 191 | 3 | 11551945 | ||
| Pubmed | 8.95e-06 | 8 | 191 | 3 | 17106278 | ||
| Pubmed | BNC2 NRAP ESR2 AHCTF1 ZFP28 ZFP37 TFE3 ZCCHC14 ZNF836 TFCP2L1 ARID5B ZBTB21 ZNF654 ZNF292 VDR ZNF646 | 1.12e-05 | 808 | 191 | 16 | 20412781 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SMG1 VPS39 DAPK1 BTAF1 CEP192 TRRAP BIRC6 MRPS22 LCLAT1 TYMS PTPN13 TENM3 TTC17 SMPD2 NUP160 | 1.16e-05 | 719 | 191 | 15 | 35337019 |
| Pubmed | 1.34e-05 | 9 | 191 | 3 | 24505475 | ||
| Pubmed | 1.34e-05 | 9 | 191 | 3 | 23170932 | ||
| Pubmed | ADCY10 DDX17 NOA1 GARS1 NUP88 NME2P1 ANKRD30B SRP72 BCOR COPS2 TRRAP MRPS22 ORC2 IGF2BP1 FASN RESF1 INTS9 DHX32 STIP1 TBR1 NUP160 | 1.59e-05 | 1335 | 191 | 21 | 29229926 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPHN DDX17 RPS6KA1 GARS1 NUP88 SRP72 UNC13D COPS2 BIRC6 TYMS FASN WASHC5 ABCE1 AGL UBA6 INTS9 STIP1 CDC73 UBE3C NUP160 HTT VAT1 | 1.81e-05 | 1455 | 191 | 22 | 22863883 |
| Pubmed | 1.90e-05 | 10 | 191 | 3 | 15784911 | ||
| Pubmed | 1.90e-05 | 10 | 191 | 3 | 12956878 | ||
| Pubmed | 1.90e-05 | 10 | 191 | 3 | 12738788 | ||
| Pubmed | 1.90e-05 | 10 | 191 | 3 | 38487272 | ||
| Pubmed | 1.90e-05 | 10 | 191 | 3 | 24550175 | ||
| Pubmed | 1.90e-05 | 10 | 191 | 3 | 8450224 | ||
| Pubmed | HECW1 MYO5B ZFP30 GNPTAB ZFP28 BIRC6 DENND3 ZNF836 TLR1 SPIDR NUP160 DOP1A | 2.02e-05 | 493 | 191 | 12 | 15368895 | |
| Pubmed | 2.23e-05 | 152 | 191 | 7 | 34299191 | ||
| Pubmed | 2.60e-05 | 11 | 191 | 3 | 23699523 | ||
| Pubmed | FASN-dependent de novo lipogenesis is required for brain development. | 2.60e-05 | 11 | 191 | 3 | 34996870 | |
| Pubmed | 2.60e-05 | 11 | 191 | 3 | 21085635 | ||
| Pubmed | 2.60e-05 | 11 | 191 | 3 | 22808111 | ||
| Pubmed | 2.81e-05 | 32 | 191 | 4 | 19449444 | ||
| Pubmed | SOX9 SOX10 ANK2 ANK3 KALRN VPS39 HLA-DRB1 GNPTAB ZNF521 RIPK4 FOCAD ZNF836 PTPN13 ARID5B TTC17 SMPD3 DNAI7 DCLK1 MED13 ZNF292 | 2.97e-05 | 1285 | 191 | 20 | 35914814 | |
| Pubmed | The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival. | 3.00e-05 | 2 | 191 | 2 | 29789657 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 24628273 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 22219324 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 16204645 | ||
| Pubmed | Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. | 3.00e-05 | 2 | 191 | 2 | 16273099 | |
| Pubmed | Structural organization of the DR subregion of the human major histocompatibility complex. | 3.00e-05 | 2 | 191 | 2 | 3860851 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 2497068 | ||
| Pubmed | T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells. | 3.00e-05 | 2 | 191 | 2 | 34630413 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 20935204 | ||
| Pubmed | Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. | 3.00e-05 | 2 | 191 | 2 | 23197535 | |
| Cytoband | 19q13.12 | 1.32e-05 | 72 | 191 | 5 | 19q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 ZNF268 ZNF875 ZNF549 ZFP30 ZNF521 ZFP28 ZNF621 ZNF354B ZFP37 ZNF404 ZNF461 ZNF594 ZNF836 ZNF33B ZNF35 ZNF341 ZNF540 ZBTB21 ZNF727 ZNF420 ZNF471 ZNF454 ZNF292 ZNF646 | 1.79e-10 | 718 | 138 | 25 | 28 |
| GeneFamily | Ankyrin repeat domain containing | 1.02e-04 | 242 | 138 | 9 | 403 | |
| GeneFamily | T-boxes | 3.26e-04 | 18 | 138 | 3 | 766 | |
| GeneFamily | Nucleoporins | 1.84e-03 | 32 | 138 | 3 | 1051 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON | 4.29e-07 | 22 | 188 | 5 | M8692 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | SMG1 IL13RA1 THOC7 GNPTAB TOR1A CPT1A TRRAP LYST ITPR2 RESF1 TAX1BP1 IRAK3 TTC17 CDC73 VAT1 | 2.01e-06 | 477 | 188 | 15 | M40930 |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 1.39e-05 | 21 | 188 | 4 | M41167 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DEPTOR ANK3 MYO5B KALRN SLC26A2 GNPTAB PIK3R3 PCDHB4 CEP192 CPT1A MAP3K5 ITPR2 FOCAD DDHD1 SMPD2 UBASH3B HS3ST1 NDRG4 DCLK1 HTT VAT1 VDR | 1.49e-05 | 1102 | 188 | 22 | M2369 |
| Coexpression | GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN | RPS6KA1 SPACA9 ITGA4 FHIP2A RASGRP1 IRAK3 TTC17 UBASH3B ZNF646 | 1.50e-05 | 200 | 188 | 9 | M6580 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DEPTOR ANK3 MYO5B KALRN SLC26A2 GNPTAB PIK3R3 PCDHB4 CEP192 CPT1A MAP3K5 ITPR2 FOCAD DDHD1 SMPD2 UBASH3B HS3ST1 NDRG4 DCLK1 HTT VAT1 VDR | 2.01e-05 | 1124 | 188 | 22 | MM1070 |
| Coexpression | GCNP_SHH_UP_EARLY.V1_DN | 2.89e-05 | 167 | 188 | 8 | M2638 | |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN | 4.93e-05 | 180 | 188 | 8 | M6317 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | DDX17 AHCTF1 GNPTAB ITGA4 BIRC6 LYST DDHD1 TTC17 POLQ ZNF292 | 9.30e-09 | 191 | 188 | 10 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.02e-07 | 186 | 188 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.82e-07 | 199 | 188 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.24e-06 | 185 | 188 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-06 | 188 | 188 | 8 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.52e-06 | 190 | 188 | 8 | 268772d2adff34f7175b8474e95b67fd96dc1234 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 195 | 188 | 8 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-06 | 197 | 188 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.99e-06 | 197 | 188 | 8 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 2.15e-06 | 199 | 188 | 8 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.17e-06 | 167 | 188 | 7 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 168 | 188 | 7 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 9.02e-06 | 173 | 188 | 7 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 178 | 188 | 7 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.09e-05 | 178 | 188 | 7 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 179 | 188 | 7 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 179 | 188 | 7 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 1.17e-05 | 180 | 188 | 7 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 70 | 188 | 5 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 1.35e-05 | 184 | 188 | 7 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 123 | 188 | 6 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 185 | 188 | 7 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 186 | 188 | 7 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.44e-05 | 186 | 188 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.55e-05 | 188 | 188 | 7 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 189 | 188 | 7 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 191 | 188 | 7 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 192 | 188 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-05 | 192 | 188 | 7 | 189477c44040cf0ee16c3932fa49fbd9e3acaa3c | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-05 | 192 | 188 | 7 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 192 | 188 | 7 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 193 | 188 | 7 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 193 | 188 | 7 | 12f1333f11e6c262954ad7912d8fd2962ab06d25 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 193 | 188 | 7 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-05 | 194 | 188 | 7 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-05 | 194 | 188 | 7 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.96e-05 | 195 | 188 | 7 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.96e-05 | 195 | 188 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 188 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-05 | 196 | 188 | 7 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.09e-05 | 197 | 188 | 7 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-05 | 197 | 188 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 199 | 188 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 199 | 188 | 7 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.30e-05 | 200 | 188 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.30e-05 | 200 | 188 | 7 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 2.30e-05 | 200 | 188 | 7 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 94 | 188 | 5 | d25f096626af873f724a8cd6454ed56e33fd9854 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 94 | 188 | 5 | 2fb80a08f823295fa4c3e6494bf020e5b4052f0f | |
| ToppCell | IIH-CD8-exh_CD4|IIH / Condition, Cell_class and T cell subcluster | 4.94e-05 | 154 | 188 | 6 | a2f51a3c5455fe2483e438375ea856afce8262fe | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.11e-05 | 160 | 188 | 6 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-05 | 161 | 188 | 6 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 6.55e-05 | 162 | 188 | 6 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-05 | 166 | 188 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-05 | 166 | 188 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.49e-05 | 166 | 188 | 6 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.75e-05 | 167 | 188 | 6 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.27e-05 | 169 | 188 | 6 | d382a76d85875663502cc7dde2e3e0682605768e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-05 | 169 | 188 | 6 | b66ffc2b2b6bfcc3a6e639d9d31d3de95f4a94e1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-05 | 169 | 188 | 6 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 171 | 188 | 6 | 562fc8a422615dbbece67ea49740f0c09bdb9ae3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.11e-05 | 172 | 188 | 6 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.11e-05 | 172 | 188 | 6 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.11e-05 | 172 | 188 | 6 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-04 | 175 | 188 | 6 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 176 | 188 | 6 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.03e-04 | 176 | 188 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 177 | 188 | 6 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.07e-04 | 177 | 188 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 1.07e-04 | 177 | 188 | 6 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 177 | 188 | 6 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 177 | 188 | 6 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.10e-04 | 178 | 188 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.17e-04 | 180 | 188 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 183 | 188 | 6 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.28e-04 | 183 | 188 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.28e-04 | 183 | 188 | 6 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.28e-04 | 183 | 188 | 6 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 184 | 188 | 6 | 9365cdc52a2419e3f27e1c1c9310fa707d1e506b | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 184 | 188 | 6 | 7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 184 | 188 | 6 | 204d16c48f822c98dc4118ac97a4f99f7e1163c8 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 184 | 188 | 6 | 53b71c4ac86dc5e42763b8f64fbc917177531017 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 185 | 188 | 6 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-04 | 185 | 188 | 6 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-04 | 186 | 188 | 6 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-04 | 186 | 188 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 186 | 188 | 6 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-04 | 186 | 188 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-04 | 187 | 188 | 6 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-04 | 187 | 188 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.44e-04 | 187 | 188 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 188 | 188 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 188 | 188 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 188 | 188 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.48e-04 | 188 | 188 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 189 | 188 | 6 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 190 | 188 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 190 | 188 | 6 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 190 | 188 | 6 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 190 | 188 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.47e-05 | 49 | 118 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Disease | Malignant neoplasm of breast | ANK2 KALRN VPS39 NOA1 ESR2 CPT1A ALS2CL MRPS22 MOSPD1 ZNF404 EOMES TYMS ZCCHC14 FASN TAX1BP1 PRKAA1 TENM1 ACCS DHX32 PLD2 CYB5R4 DOP1A VDR ZNF646 | 6.07e-08 | 1074 | 183 | 24 | C0006142 |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 3.73e-05 | 11 | 183 | 3 | DOID:0080822 (is_implicated_in) | |
| Disease | lymphocyte count | AOC1 KALRN HLA-DRB1 RPS6KA1 TBX21 NUP88 NME2P1 CDH23 EXTL2 ITGA4 LYST DENND3 ITPR2 EOMES FOCAD SAG DEF6 ARID5B STIP1 UBASH3B NUP160 VAV1 HTT | 4.09e-05 | 1464 | 183 | 23 | EFO_0004587 |
| Disease | Graves' disease (is_implicated_in) | 9.94e-05 | 39 | 183 | 4 | DOID:12361 (is_implicated_in) | |
| Disease | response to anticonvulsant | 1.91e-04 | 85 | 183 | 5 | GO_0036277 | |
| Disease | torsion dystonia 1 (implicated_via_orthology) | 2.28e-04 | 4 | 183 | 2 | DOID:0060730 (implicated_via_orthology) | |
| Disease | Partial Fetal Alcohol Syndrome | 3.78e-04 | 5 | 183 | 2 | C3661483 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 3.78e-04 | 5 | 183 | 2 | C0814154 | |
| Disease | Huntington's disease (is_implicated_in) | 3.79e-04 | 23 | 183 | 3 | DOID:12858 (is_implicated_in) | |
| Disease | asthma (is_implicated_in) | 4.57e-04 | 157 | 183 | 6 | DOID:2841 (is_implicated_in) | |
| Disease | rheumatoid arthritis (is_implicated_in) | 4.68e-04 | 58 | 183 | 4 | DOID:7148 (is_implicated_in) | |
| Disease | Intellectual Disability | 5.09e-04 | 447 | 183 | 10 | C3714756 | |
| Disease | extranodal nasal NK/T cell lymphoma | 5.65e-04 | 6 | 183 | 2 | MONDO_0019472 | |
| Disease | Alcohol Related Birth Defect | 5.65e-04 | 6 | 183 | 2 | C3146244 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 6.41e-04 | 63 | 183 | 4 | EFO_0022239 | |
| Disease | susceptibility to hepatitis B infection measurement | 6.80e-04 | 64 | 183 | 4 | EFO_0008405 | |
| Disease | tuberculosis (is_implicated_in) | 6.86e-04 | 28 | 183 | 3 | DOID:399 (is_implicated_in) | |
| Disease | alopecia (is_implicated_in) | 7.87e-04 | 7 | 183 | 2 | DOID:987 (is_implicated_in) | |
| Disease | tumor necrosis factor receptor superfamily member 6 measurement | 7.87e-04 | 7 | 183 | 2 | EFO_0010610 | |
| Disease | neutrophil count | BNC2 THOC7 HLA-DRB1 HLA-DRB3 PIK3R3 NUP88 CDH23 TEX14 ITGA4 MAP3K5 ITPR2 AP4E1 DEF6 MIPEP UBASH3B NUP160 HTT ZNF292 VAT1 | 1.01e-03 | 1382 | 183 | 19 | EFO_0004833 |
| Disease | leprosy (is_implicated_in) | 1.05e-03 | 8 | 183 | 2 | DOID:1024 (is_implicated_in) | |
| Disease | Pure Gonadal Dysgenesis, 46, XX | 1.05e-03 | 8 | 183 | 2 | C0685837 | |
| Disease | Gonadal Dysgenesis, 46,XX | 1.05e-03 | 8 | 183 | 2 | C0949595 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 1.05e-03 | 8 | 183 | 2 | EFO_0801768 | |
| Disease | Head and Neck Neoplasms | 1.12e-03 | 33 | 183 | 3 | C0018671 | |
| Disease | Schizophrenia | SOX10 DYM HTR1F ANK3 MYO5B MYO9B VPS39 HLA-DRB1 ESR2 ALS2CL TRRAP HTR3B MAPK3 DCLK1 | 1.28e-03 | 883 | 183 | 14 | C0036341 |
| Disease | Parkinson's disease (is_implicated_in) | 1.30e-03 | 76 | 183 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | Abnormality of the face | 1.34e-03 | 9 | 183 | 2 | C4025871 | |
| Disease | mean corpuscular hemoglobin concentration | KALRN MYO9B RPS6KA1 PIK3R3 GARS1 ITPR2 FOCAD TYMS BBS7 PRKAA1 DHX32 EIF2AK4 UBE3C ZNF654 MED13 DYRK3 | 1.50e-03 | 1105 | 183 | 16 | EFO_0004528 |
| Disease | Colorectal Carcinoma | ANK2 KALRN ESR2 SETD4 PPOX TYMS ABCE1 ZNF540 TENM1 ZNF471 DCLK1 ZNF292 | 1.52e-03 | 702 | 183 | 12 | C0009402 |
| Disease | neutrophil percentage of leukocytes | KALRN HLA-DRB1 PIK3R3 CDH23 EXTL2 ITGA4 ARID5B UBASH3B NUP160 HTT ZNF292 | 1.57e-03 | 610 | 183 | 11 | EFO_0007990 |
| Disease | celiac disease (is_implicated_in) | 1.67e-03 | 10 | 183 | 2 | DOID:10608 (is_implicated_in) | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 1.82e-03 | 39 | 183 | 3 | DOID:526 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 2.03e-03 | 11 | 183 | 2 | OBA_2045197 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 2.03e-03 | 11 | 183 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.05e-03 | 86 | 183 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | Carcinoma, Transitional Cell | 2.10e-03 | 41 | 183 | 3 | C0007138 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 2.26e-03 | 42 | 183 | 3 | DOID:612 (is_implicated_in) | |
| Disease | eosinophil count | BNC2 HLA-DRB1 HLA-DRB3 TBX21 UNC13D EXTL2 ITGA4 LCLAT1 MAP3K5 EOMES RASGRP1 IGF2BP1 RESF1 MRO FNIP1 ZNF420 SPIDR ZNF292 VDR | 2.34e-03 | 1488 | 183 | 19 | EFO_0004842 |
| Disease | dystonia (implicated_via_orthology) | 2.42e-03 | 12 | 183 | 2 | DOID:543 (implicated_via_orthology) | |
| Disease | breast cancer (is_implicated_in) | 2.49e-03 | 150 | 183 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | gait measurement | 2.49e-03 | 150 | 183 | 5 | EFO_0007680 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.49e-03 | 150 | 183 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Malignant Head and Neck Neoplasm | 2.58e-03 | 44 | 183 | 3 | C0278996 | |
| Disease | Gastric Adenocarcinoma | 2.75e-03 | 45 | 183 | 3 | C0278701 | |
| Disease | potassium measurement | 2.75e-03 | 45 | 183 | 3 | EFO_0009283 | |
| Disease | Fetal Alcohol Spectrum Disorders | 2.85e-03 | 13 | 183 | 2 | C2985290 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 2.85e-03 | 13 | 183 | 2 | DOID:676 (is_implicated_in) | |
| Disease | autoimmune hepatitis (is_implicated_in) | 2.85e-03 | 13 | 183 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | Granulomatosis with Polyangiitis | 2.85e-03 | 13 | 183 | 2 | EFO_0005297 | |
| Disease | lymphocyte percentage of leukocytes | AOC1 HLA-DRB1 PIK3R3 CDH23 EXTL2 ITGA4 FASN ARID5B UBASH3B ZNF292 VDR | 3.05e-03 | 665 | 183 | 11 | EFO_0007993 |
| Disease | Bipolar Disorder | ANK3 RAPGEF5 HLA-DRB1 HLA-DRB4 RASGRP1 TRANK1 HTR3B DCLK1 VDR | 3.07e-03 | 477 | 183 | 9 | C0005586 |
| Disease | coronary artery disease | CDK8 ANKRD31 TDRD15 ASZ1 MYO9B ZNF268 NOA1 RPS6KA1 UNC13D ALS2CL AP4E1 IGF2BP1 ZNF727 UBASH3B NUP160 VAT1 | 3.24e-03 | 1194 | 183 | 16 | EFO_0001645 |
| Disease | trimethylamine-N-oxide measurement | 3.31e-03 | 14 | 183 | 2 | EFO_0010541 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.51e-03 | 49 | 183 | 3 | EFO_0022256 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.81e-03 | 15 | 183 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Major Depressive Disorder | 4.20e-03 | 243 | 183 | 6 | C1269683 | |
| Disease | autism spectrum disorder (is_implicated_in) | 4.34e-03 | 16 | 183 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | response to haloperidol | 4.34e-03 | 16 | 183 | 2 | GO_1905119 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 4.38e-03 | 53 | 183 | 3 | EFO_0022340 | |
| Disease | alkaline phosphatase measurement | TDRD15 AOC1 HLA-DRB1 ZFP28 SPACA9 CPT1A FHIP2A LCLAT1 IGF2BP1 NWD2 SAG TRANK1 UBASH3B NUP160 | 4.51e-03 | 1015 | 183 | 14 | EFO_0004533 |
| Disease | cholesterol to total lipids in very large VLDL percentage | 4.61e-03 | 54 | 183 | 3 | EFO_0022244 | |
| Disease | melanoma | 4.64e-03 | 248 | 183 | 6 | C0025202 | |
| Disease | Astrocytosis | 4.89e-03 | 17 | 183 | 2 | C3887640 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 4.89e-03 | 17 | 183 | 2 | OBA_2045173 | |
| Disease | Gliosis | 4.89e-03 | 17 | 183 | 2 | C0017639 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.89e-03 | 17 | 183 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Fetal Alcohol Syndrome | 4.89e-03 | 17 | 183 | 2 | C0015923 | |
| Disease | hemoglobin A1 measurement | IL13RA1 MYO9B RPS6KA1 UNC13D EOMES RASGRP1 CBFA2T2 UBE3C UBASH3B | 5.36e-03 | 520 | 183 | 9 | EFO_0007629 |
| Disease | free cholesterol measurement | 5.45e-03 | 113 | 183 | 4 | EFO_0008591 | |
| Disease | Feeding difficulties | 5.48e-03 | 18 | 183 | 2 | C0232466 | |
| Disease | esophageal adenocarcinoma | 5.48e-03 | 18 | 183 | 2 | EFO_0000478 | |
| Disease | Libman-Sacks Disease | 5.64e-03 | 58 | 183 | 3 | C0242380 | |
| Disease | Unipolar Depression | 5.71e-03 | 259 | 183 | 6 | C0041696 | |
| Disease | myeloid white cell count | THOC7 HLA-DRB1 PIK3R3 CDH23 EXTL2 ITGA4 MAP3K5 EOMES UBASH3B NUP160 HTT ZNF292 VAT1 | 5.85e-03 | 937 | 183 | 13 | EFO_0007988 |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 5.91e-03 | 59 | 183 | 3 | EFO_0022289 | |
| Disease | Autistic Disorder | 5.92e-03 | 261 | 183 | 6 | C0004352 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 6.10e-03 | 19 | 183 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | hepatitis B virus infection | 6.10e-03 | 19 | 183 | 2 | EFO_0004197 | |
| Disease | osteoporosis (implicated_via_orthology) | 6.10e-03 | 19 | 183 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | Cocaine-Related Disorders | 6.16e-03 | 117 | 183 | 4 | C0236736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IIAILLDAHHKTYDP | 131 | P11473 | |
| QPLAHHVQQYVLLLL | 156 | Q60I27 | |
| QSLHKYQPRLHIVEV | 391 | O95936 | |
| LTVKHYLSPQQLREH | 1231 | P53355 | |
| CQVRQYHIKPLSLHQ | 481 | Q8IWZ6 | |
| NYIHQQLLEHIRKLP | 251 | Q9BXX2 | |
| HSLSYHPALNAILAV | 71 | Q9NR09 | |
| ALYEQSLHIKSAIPH | 216 | P61201 | |
| LFLLNNVHLSHPVYV | 61 | Q6P1J9 | |
| LAYHVQSFLSEHNKP | 126 | Q9P2K8 | |
| VYLPENHARLKAAHT | 376 | Q96QU6 | |
| AAIIVTRKLHHPANY | 46 | P30939 | |
| LDKLSTQHLYHPTQV | 146 | Q6ZN30 | |
| TEILHNIDPLYNHAQ | 386 | Q5FYB1 | |
| HPQDSALYHLSKQLL | 26 | O95264 | |
| HKLLALYNHISELVQ | 381 | O95267 | |
| PDAFVQLALQLAHYK | 566 | P50416 | |
| TPQHHQKSVELFYQL | 886 | Q5JWR5 | |
| KSPNFNIHPLYQHVL | 1356 | Q5JWR5 | |
| PLHLAVSLNKEIYFH | 206 | P10523 | |
| PYNLISLFLHIHVEK | 1166 | Q96PN6 | |
| LYHTLQEATKPLHQF | 151 | P19801 | |
| LTHKQVAQLHPLSGY | 641 | Q7L7V1 | |
| HKDPHYVQQALTNVL | 821 | A2RUS2 | |
| NHLEDPHYSELTNLK | 1181 | Q6W2J9 | |
| FLKILQPGHSHLYNN | 21 | Q8N4T0 | |
| ITAIDHDLNPKLEYH | 2196 | Q9H251 | |
| KHHEIFNLLSFTLNP | 226 | Q8WWH4 | |
| ALYKFHLIAPNQVQH | 191 | Q9UPM8 | |
| IVHNYILPSKAGHIN | 396 | Q9ULI1 | |
| ELIQTNKLKHYPSIH | 366 | Q9NV88 | |
| YLKQVLDIDLHAQIH | 581 | Q9NQX3 | |
| PKDVGHNIYILAHQL | 2101 | Q14571 | |
| GLTPLHVAAHYDNQK | 596 | Q01484 | |
| HVAAHYDNQKVALLL | 601 | Q01484 | |
| QPHTLQEQHHVLYKS | 856 | Q8N7Z5 | |
| HLIKTQDLDPSHNYI | 91 | Q96PD6 | |
| YLHSINIAHRDVKPE | 176 | P49137 | |
| VHRQLSHLYAEPQKS | 91 | Q92731 | |
| HELYKVILLPNQTHY | 541 | Q3T906 | |
| HYHSLPAQDNLVLKQ | 346 | Q86VF7 | |
| HQHESLPLAYNDKIV | 1106 | Q76N89 | |
| GHQLENHALKVSYIP | 141 | Q9NZI8 | |
| LACYRLLHKQPHLNS | 396 | Q6UWP7 | |
| YLHSLNIVHRDIKPE | 501 | O15075 | |
| KLLNHYQAVPNLHKV | 81 | Q9UBQ6 | |
| RLLENQYKSLHDPHL | 91 | Q5CZC0 | |
| NHLTDLSPLNYLTHL | 101 | Q53EV4 | |
| AKQTPSQYLAQHEHL | 196 | O43439 | |
| KIIYITQLPPALHHN | 1041 | Q6ZWH5 | |
| LAQVQHPLLHYLSVH | 116 | Q86V87 | |
| PQHVHILLANLYVAV | 271 | Q96RD2 | |
| DVPNYRLIKENSHLH | 61 | B0L3A2 | |
| LLQHLQHPQYITLHD | 2731 | O60229 | |
| PLYLHLSVNQKLVAA | 186 | Q9UJG1 | |
| LKPRYIVHLGQHNLQ | 96 | Q9UBX7 | |
| KLYQQLSHYHPEILQ | 226 | Q9BYG7 | |
| YIHSANVLHRDLKPS | 156 | P27361 | |
| KAIHYLHNVQPCSVI | 276 | Q9Y616 | |
| KLEQQHSLFTHYRDP | 521 | Q9NY59 | |
| QIALQRHLLPASHYV | 226 | P46089 | |
| PHIKNLSFHNDDLYV | 231 | P78552 | |
| IALNRYLKVVQPHHV | 186 | Q8TDS5 | |
| LQKYTISPNSHFHIL | 166 | Q9Y5E5 | |
| SKHPIQELTQHIYTL | 86 | O60906 | |
| DIHKHLPFIYNLSSN | 211 | O15488 | |
| HHESLAQYNPKLDVK | 141 | Q92569 | |
| YPAKTQPLQHHNLLV | 131 | P79483 | |
| QLLHEKIRDAYTHPQ | 426 | P61221 | |
| AQYLVVVSKLPSHLH | 2226 | P42858 | |
| HPHELNNLLSKVLIY | 36 | O14981 | |
| SLHHNPNLVYALLYK | 546 | Q7RTS9 | |
| LLHSTLQLYKHNLSP | 1086 | Q8TF40 | |
| FYNLHHQAEGLVKPS | 361 | O75417 | |
| HVSNKHPFVDSNLLY | 201 | Q8TB45 | |
| FNHTNPELHKELLKY | 86 | Q7Z4T8 | |
| RHSHFYVIINNKVPL | 576 | Q6TDU7 | |
| YPSKTQPLQHHNLLV | 131 | P01911 | |
| PLHVAAHYDNQKVAL | 601 | Q12955 | |
| YPSKTQPLQHHNLLV | 131 | P13762 | |
| LKVLSHNLYTVLHIP | 31 | Q9H4E7 | |
| EPHHLKNLQPTEYKT | 1786 | Q99698 | |
| SLVNLKQVIIHAAHY | 591 | P49641 | |
| QIEAAYHLGPHVISK | 576 | P13612 | |
| QKDYSHVRHFLPNDL | 756 | Q8TEP8 | |
| YKILQQIPDHPKHFS | 281 | Q08554 | |
| NLSHPGQKALLHYNE | 131 | Q9NPA1 | |
| VHHLQRANYVPALKL | 956 | Q8WYP5 | |
| LILKHYSNISPVQIH | 671 | Q8NEL9 | |
| KTLAYLLPAIVHINH | 221 | Q92841 | |
| EHLLQKPNEHILYNL | 476 | Q5W0V3 | |
| HIDPATHRQKLYTLQ | 1056 | P49327 | |
| HVPNVTSLCLQYIKH | 296 | O75155 | |
| IKTSNPYHHDQLDRI | 241 | P49336 | |
| SSLRAKYPHDVVNHL | 111 | Q96E40 | |
| LTPEQALKQYKHHLT | 141 | O43781 | |
| ALYQKHAGHTLLQIP | 576 | Q8NC60 | |
| EKNIQSIYTIRNHPH | 121 | Q5VW36 | |
| HDLSQASLYPHRKNV | 971 | Q12923 | |
| IYQVLLSPTQHHVAL | 111 | Q99567 | |
| QVDPKLLNKLHEYFH | 276 | O14792 | |
| SRYSQPLHEEIALHK | 716 | Q99683 | |
| HNIYLIASIDHLNAP | 416 | Q13416 | |
| DATNLVQLYHVLHPD | 296 | P82650 | |
| NVAKSYLPNAHLECH | 21 | Q86VP1 | |
| QEHSSKLRHPYLLQL | 296 | Q8IWB6 | |
| VLQSLHKYQPRLHVV | 326 | Q16650 | |
| IKLDPHNHVLYSNRS | 31 | P31948 | |
| YAEILKHIIHPAQAQ | 386 | Q5H9J9 | |
| VIIHPNHLYNLVDLQ | 906 | B5MCY1 | |
| IHSDKAPVLYLHDQL | 1041 | Q9HCM1 | |
| RHPLYQKHQQALEVV | 346 | Q0VDG4 | |
| LPASEEHLKQHYIDL | 26 | O60361 | |
| LHHYATVALQYPKAI | 2641 | Q96Q15 | |
| DHPKFQNVADLHLYL | 361 | P41250 | |
| KYHVLHINTTKNNPV | 101 | Q7LGA3 | |
| SPKEHQELKSYVNHL | 546 | Q92565 | |
| YLDLLNHSPHVQVKA | 231 | Q9NVD3 | |
| QITIHHPIYLKFNIS | 421 | Q9UKZ4 | |
| PAILTYHDVGLNHKL | 31 | Q9ULP0 | |
| RKLADQYPHLHNAEL | 121 | P48436 | |
| QYPHLHNAELSKTLG | 126 | P48436 | |
| HEDREIYPQHLKSLA | 1701 | Q9UHV7 | |
| YQNHQPKSPAHLSLI | 436 | O76094 | |
| EKIANLYSISPQHIH | 416 | Q9NZI6 | |
| THLQVPIGQHVYLKL | 301 | Q7L1T6 | |
| LQYQEALSHPLALHL | 536 | Q12769 | |
| HLDLKPANILLDAHY | 141 | P57078 | |
| PANILLDAHYHVKIS | 146 | P57078 | |
| HPTVNLKHLDLSFNA | 111 | Q15399 | |
| LETVVNHIKHRYPQA | 181 | Q96SE0 | |
| NHQDPLAVAYHLIID | 326 | Q13131 | |
| HHLNPLADSYVLKQE | 791 | Q14865 | |
| LQAQSHLHGIKPRYT | 141 | P25874 | |
| LVHLHKNCIPQYTLG | 411 | P50336 | |
| AVLKHIAELNPYVHV | 121 | A0AVT1 | |
| AHLHAQAKPYENISL | 236 | Q9NUW8 | |
| ALSQHNRIHTGEKPY | 326 | A8MUV8 | |
| NLIVHQRSHTGEKPY | 376 | P13682 | |
| QLATHQRIHTGEKPY | 631 | Q8NHY6 | |
| DTIAKYLDNIHLHPE | 176 | Q9BZV1 | |
| HYINPAHAISLLSAL | 6 | Q9ULJ3 | |
| LHEFPQYVKTHLALA | 331 | Q7RTX0 | |
| VNKYSTPEALEHHLQ | 546 | Q9BYN7 | |
| TFTLYPQLNRHQKIH | 251 | Q8NDQ6 | |
| ILYFEPSILHTHQAK | 261 | Q12768 | |
| SLIQHQKVHSGERPY | 571 | Q6P9A3 | |
| QLNLHQRIHTGEKPY | 256 | Q9Y2G7 | |
| ALIVHQRTHTQEKPY | 651 | Q06732 | |
| QLISHQRTHAGEKPY | 766 | Q14587 | |
| LHFPHASNITLYKDQ | 136 | O14656 | |
| TLDQIYHGKHPLRNS | 581 | Q99797 | |
| VLKVQTHLENPTRYH | 176 | P19532 | |
| KLHENYNSSIAGHIP | 351 | P50443 | |
| NVLLIDSESPHKYHV | 196 | Q14159 | |
| YHLLLQELVKHTQEA | 336 | P15498 | |
| LPSLYNLNEHLKQVH | 446 | Q96K83 | |
| KLADQYPHLHNAELS | 121 | P56693 | |
| LILHYQAVHKSDLPA | 2131 | O60281 | |
| SLLNHQKAHTTGLYP | 1691 | O15015 | |
| NKINEPSTYKLIHHP | 1106 | Q9HCK1 | |
| NHPEISKDLYFHQAL | 221 | Q8IZM8 | |
| HIYLNHIEPLKIQLQ | 256 | P04818 | |
| LDKHHVLDVQNGILY | 1116 | Q9P273 | |
| RQEYDALAKVIQHHP | 116 | Q6I9Y2 | |
| TKILELPYSIHAFQH | 161 | Q96AE7 | |
| KDSYHNLRLSIHDVP | 646 | Q6ZN44 | |
| SYLIQHQIIHTDLKP | 396 | Q494X3 | |
| YLASLPSHVLKNDHV | 181 | Q8WYQ9 | |
| ALTQHQRIHTGEKPY | 221 | Q6ZSS3 | |
| LALYNQGHIKPHIDS | 346 | Q99536 | |
| QLATHQRIHTGEKPY | 501 | Q9BX82 | |
| ALAQHQRIHTGEKPY | 426 | Q8N9F8 | |
| QLSLHQRLHTGEKPY | 181 | Q8TAQ5 | |
| NLIIHQRIHTGNKPY | 141 | Q96JF6 | |
| NLTIHQRIHSGEKPY | 86 | Q9NSJ1 | |
| NLITHQRAHTGEKPY | 371 | P10072 | |
| AYHFQASHLPTLEKL | 216 | Q8TF42 | |
| ALIQHQRTHTGEKPY | 256 | Q96LW1 | |
| SHYKPLDPNIHKLQD | 1176 | O15050 | |
| HPFLAIYELQSLKVH | 41 | O14939 | |
| NLIQHVRSHTGEKPY | 391 | Q9Y6Q3 | |
| KHALYQLLAHPNFTE | 981 | Q9Y4A5 | |
| PSYTVHLHLLQQLVS | 296 | Q70J99 | |
| QSLHKYQPRLHIVEV | 261 | Q9UL17 | |
| NPYTELLVLKAHHDI | 31 | Q9HAD4 | |
| NLAIHQRIHTGEKPY | 316 | Q6ZNA1 | |
| LTQHQRLHTGEKPYE | 316 | Q8TAF7 | |
| STLHFPHEQKIKLYQ | 141 | O14657 | |
| IHHLASLDPEVYKNL | 856 | Q15386 | |
| SPLKGHERTVQYLQH | 531 | Q96JC1 | |
| HPECAYNLVNSPHLK | 231 | P35573 | |
| LADVNHPFVVKLHYA | 116 | Q15418 | |
| ALSYLHEPAVLHNLK | 76 | Q9ULV0 | |
| AIYAVLEHLPEANHN | 1806 | Q13459 |